International Biotechnology Trust’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $3.12M | Buy |
91,500
+66,000
| +259% | +$2.25M | 1.05% | 31 |
|
|
2023
Q2 | $982K | Hold |
25,500
| – | – | 0.3% | 45 |
|
|
2023
Q1 | $912K | Hold |
25,500
| – | – | 0.25% | 51 |
|
|
2022
Q4 | $1M | Hold |
25,500
| – | – | 0.31% | 50 |
|
|
2022
Q3 | $918K | Buy |
25,500
+24,726
| +3,195% | +$890K | 0.29% | 53 |
|
|
2022
Q2 | $25.5K | Sell |
774
-24,726
| -97% | -$815K | 0.27% | 59 |
|
|
2022
Q1 | $3.2M | Hold |
25,500
| – | – | 0.72% | 34 |
|
|
2021
Q4 | $797K | Hold |
25,500
| – | – | 0.18% | 62 |
|
|
2021
Q3 | $388K | Hold |
25,500
| – | – | 0.09% | 62 |
|
|
2021
Q2 | $474K | Buy |
+25,500
| New | +$474K | 0.13% | 62 |
|